scispace - formally typeset
R

Rosemary B. Duda

Researcher at Harvard University

Publications -  72
Citations -  5609

Rosemary B. Duda is an academic researcher from Harvard University. The author has contributed to research in topics: Breast cancer & Population. The author has an hindex of 31, co-authored 72 publications receiving 4350 citations. Previous affiliations of Rosemary B. Duda include Beth Israel Deaconess Medical Center & Northwestern University.

Papers
More filters
Journal ArticleDOI

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Bin Zhou, +1144 more
- 11 Sep 2021 - 
TL;DR: In this article, a Bayesian hierarchical model was used to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control).
Journal ArticleDOI

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

Robert J. Soiffer, +26 more
- 27 Oct 1998 - 
TL;DR: It is demonstrated that vaccination with irradiated autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor stimulates potent antitumor immunity in humans with metastatic melanoma.
Journal ArticleDOI

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy

Stuart J. Schnitt, +10 more
- 15 Sep 1994 - 
TL;DR: The relationships among the involvement of tumor at the final margins of resection, the presence of an extensive intraductal component (EIC), and the risk of local recurrence in patients treated with conservative surgery and radiation therapy for early stage breast cancer have not been defined adequately.
Journal ArticleDOI

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.

Michael G. FitzGerald, +18 more
- 18 Jan 1996 - 
TL;DR: Germ-line BRCA1 mutations can be present in young women with breast cancer who do not belong to families with multiple affected members and are strongly associated with the onset of breast cancer in Jewish women before the age of 40.
Journal ArticleDOI

Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer.

Sumner A. Slavin, +7 more
- 01 Jul 1998 - 
TL;DR: Although these results need to be confirmed with greater numbers of patients and longer follow‐up, skin‐sparing mastectomy and immediate breast reconstruction may be considered an excellent alternative treatment to breast conservation for patients with ductal carcinoma in situ and early‐stage invasive breast cancer.